Priority Applications (3) Applications Claiming Priority (2) Publications (1) Family ID=67805224 Family Applications (1) Country Status (4) Cited By (2) Citations (1) Family Cites Families (8) 2019 2019-02-27 US US16/976,304 patent/US12151031B2/en active Active 2019-02-27 WO PCT/IN2019/050161 patent/WO2019167070A1/en not_active Ceased 2019-02-27 EP EP19760988.6A patent/EP3758731A4/en active Pending 2019-02-27 CA CA3092487A patent/CA3092487A1/en active Pending
Many opt to split their daily B vitamin dose to extend optimized cellular function
GLP3, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
E.BurtonD.ShinA.JeongI
J Pediatr Surg
It may promote the growth of new blood vessels, enhance blood flow, and improve cardiac function, potentially benefiting individuals with cardiovascular conditions